How a brain chemical affects opioid addiction and reward
Contribution of locus coeruleus-derived galanin to opioid reward and reinforcement
This study is looking at how a brain chemical called galanin affects opioid addiction and the feelings of pleasure that come with it, using specially modified mice to see how changes in galanin might help us find better ways to treat people struggling with opioid use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10886527 on NIH RePORTER |
What this research studies
This research investigates the role of a brain chemical called galanin in opioid addiction and reward mechanisms. By studying genetically altered mice, the researchers aim to understand how galanin influences the brain's reward pathways and opioid intake behaviors. The project focuses on the locus coeruleus, a brain region involved in addiction, to explore how changes in galanin levels can affect opioid reinforcement and withdrawal symptoms. The findings could lead to new therapeutic approaches for treating opioid addiction.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals struggling with opioid addiction or those at risk of developing opioid use disorders.
Not a fit: Patients who are not affected by opioid addiction or who do not use opioids may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for opioid addiction that are less likely to be abused and more effective for patients.
How similar studies have performed: Previous research has shown promising results in targeting brain chemicals like galanin for addiction treatment, indicating potential for success in this approach.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Weinshenker, David — Emory University
- Study coordinator: Weinshenker, David
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.